Lumos Diagnostics CEO Doug Ward joined Steve Darling from Proactive to discuss the company’s recent achievement of CLIA ...
New regulations under the Clinical Laboratory Improvement Amendments (CLIA) introduced updated proficiency testing (PT) and PT referral rules that are now in effect. Although the regulations became ...
QuidelOrtho Corporation QDEL recently announced that it has been granted a CLIA Waiver by the FDA, which applies to its new Sofia 2 SARS Antigen+ FIA (fluorescent immunoassay). The Sofia 2 SARS ...
BOSTON--(BUSINESS WIRE)--binx health, a healthcare technology and women’s health company focused on making routine testing broadly accessible and convenient, announced today the launch of its ...
The chemiluminescence immunoassay (CLIA) market is expected to grow from USD 11.58 billion in 2026 to USD 16.39 billion by ...